Research spanning more than 20 years has led the UPV/EHU's Neurochemistry and Neurodegeneration group under Dr. Rafael Rodríguez-Puertas to discover a promising avenue for the development of new ...

Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that ...

In the pivotal Phase 3 VIVID-1 trial, patients treated with Omvoh experienced significant improvement in clinical remission and endoscopic respons ...

In “Forever Bound,” Tarka offers an unfiltered look at the reality of Alzheimer’s disease on caregivers to help others feel less alone. Having found the courage to be honest about his experience, ...

Blarcamesine potential novel oral treatment to target upstream Alzheimer’s disease pathology through autophagy enhancementImpairment of autophagy ...

A study by Kanazawa University has linked daily green tea consumption to reduced white matter lesions in older adults without ...

The headset, developed by researchers at Cornell University in New York, could help reveal how the brain navigates and ...

Beckman Coulter Diagnostics, a global leader in advanced diagnostics, today announced availability of new Research Use Only (RUO) blood-based biomarker immunoassays designed to advance ...

Older studies estimated a lower risk of dementia. According to new research, the number of people living with the disease in ...

The researchers suggest that their estimates are higher because they took extra measures to avoid underestimating the number ...

Former Premier League footballer Dean Windass has confirmed he has been diagnosed with stage two dementia. The 55-year-old took to X to confirm the news after ex-Manchester United defender David May ...